Maximizing The Potential Of Mature Brands With Key Lifecycle Management Strategies Tailored To The Pharmaceutical Industry
CHAPEL HILL, N.C., Feb. 15, 2013 /PRNewswire/ -- With expiring patents and thin pipelines, pharmaceutical companies are increasingly focused on lifecycle management (LCM) to make the most of each brand at every stage of its life, including the somewhat neglected back end. In this context, brand executives are exploring strategies and corporate structures that are most effective for extending the commercial life of a mature product.
To help guide lifecycle management decisions, research and consulting leader Best Practices, LLC conducted a research study to examine the effectiveness of 20 key lifecycle management strategies for extending the commercial life of mature pharmaceutical therapies. The study evaluates each strategy by asking: How long do they take to implement, how much do they cost and how much will they return?
An example of one of the many insights in this study: Benchmark partners believe strategic pricing strategies most often cost less than any of the others probed in the study. Two-thirds who used this strategy found the cost was less than $1 Million ($US) compared with only 50 percent for re-positioning, which was the next cheapest strategy. Moving into emerging markets costs over $10 million, according to 40 percent of participants.
" Lifecycle Management Excellence: High-Performing Strategies Used to Maximize Potential of Mature Brands" will help biopharmaceutical companies more effectively conduct the many activities related to lifecycle management.
The report addresses three over-arching issues that are integral to lifecycle management:- Success rates & ROI of different strategies that leading companies have used to maximize mature-brand value.
- Relative cost, time, complexity, & regulatory barriers encountered with using each strategy.
- An overview of the operation, expenses, responsibilities & business impact of dedicated mature brand (MB) groups.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
